Cannabis Strategic Ventures Stock Short Ratio
NUGS Stock | USD 0.0001 0.00 0.00% |
Cannabis Strategic Ventures fundamentals help investors to digest information that contributes to Cannabis Strategic's financial success or failures. It also enables traders to predict the movement of Cannabis Pink Sheet. The fundamental analysis module provides a way to measure Cannabis Strategic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabis Strategic pink sheet.
Cannabis |
Cannabis Strategic Ventures Company Short Ratio Analysis
Cannabis Strategic's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
Based on the latest financial disclosure, Cannabis Strategic Ventures has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
All Next | Launch Module |
Cannabis Fundamentals
Return On Asset | -0.2 | |||
Profit Margin | (0.39) % | |||
Operating Margin | (0.36) % | |||
Current Valuation | 25.44 M | |||
Shares Outstanding | 268.88 M | |||
Price To Book | 113.91 X | |||
Price To Sales | 0.26 X | |||
Revenue | 14.6 M | |||
Gross Profit | 2.78 M | |||
EBITDA | (4.93 M) | |||
Net Income | (5.64 M) | |||
Cash And Equivalents | 402.8 K | |||
Total Debt | 21.67 M | |||
Current Ratio | 0.21 X | |||
Book Value Per Share | (0.03) X | |||
Cash Flow From Operations | (4.09 M) | |||
Earnings Per Share | (0.02) X | |||
Number Of Employees | 30 | |||
Beta | 1.34 | |||
Market Capitalization | 3.54 M |
About Cannabis Strategic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabis Strategic Ventures's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabis Strategic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabis Strategic Ventures based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cannabis Pink Sheet Analysis
When running Cannabis Strategic's price analysis, check to measure Cannabis Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Strategic is operating at the current time. Most of Cannabis Strategic's value examination focuses on studying past and present price action to predict the probability of Cannabis Strategic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Strategic's price. Additionally, you may evaluate how the addition of Cannabis Strategic to your portfolios can decrease your overall portfolio volatility.